2020 Recap: From the CEO
Dear Shareholders,
Welcome to our first end of year newsletter as an ASX-listed company.
While 2020 has been challenging in ways no one predicted, as we reach the final days of December, I find myself looking back over the past 12 months with a sense of accomplishment and sincere gratitude.
Against the backdrop of a global pandemic and associated restrictions, I am extremely proud of the way our employees banded together to serve their communities, care for their family and neighbours, and cultivate creative ways to work remotely. The dedication of our staff has allowed for continuous growth on all fronts of the business, as well as achieving milestones we have been working towards since founding the Company over 7 years ago.
Having received regulatory clearance in the U.S. and in Australia earlier than expected, we have been able to fast track the commencement of our commercial operations. One such example is the establishment of our first research program in the U.S. with the University of Miami Health System, where our XV Technology™ will be at the centre of a number of preclinical and clinical studies. The significance of this multi-hospital, multi-indication lung imaging program cannot be understated, as the success of the program will provide the Company with a nationally recognised reference site for our technology.
In Australia, we’ve recently announced the first commercial use of XV LVAS™ (XV Lung Ventilation Analysis Software). The XV LVAS scan and report was successfully completed in Victoria and provided us with the validation needed to commence the roll-out of our technology nationally. Additional detail of these two initiatives, among others, are outlined in the section below.
All this concurrent activity has facilitated the significant growth in 4DMedical staff numbers. We have identified some of the recently appointed positions later in this newsletter.
As we look ahead to 2021, our outlook is positive as we embark on potentially our busiest and best year yet. To those who have supported 4DMedical and our mission to improve global lung health throughout the years, you have my heartfelt appreciation and sincere gratitude. Please be safe and well over the Australian summer break, and I look forward to you joining us on the journey as we continue delivering on our goals over the coming 12 months.
Faithfully,
(20min delay)